Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Total	Revision of prior period, reclassification, adjustment [Member]	Preferred stock [Member]	Preferred stock [Member] Revision of prior period, reclassification, adjustment [Member]	Common stock [Member]	Common stock [Member] Revision of prior period, reclassification, adjustment [Member]	Additional paid in capital [Member]	Additional paid in capital [Member] Revision of prior period, reclassification, adjustment [Member]	Accumulated equity (deficit) [Member]	Accumulated equity (deficit) [Member] Revision of prior period, reclassification, adjustment [Member]
Beginning Balance at Dec. 31, 2022	$ 12,303,941	$ 12,303,941	$ 16,923	$ 8,062	$ 8,102	$ 4,529	$ 71,437,087	$ 71,449,521	$ (59,158,171)	$ (59,158,171)
Beginning Balance, shares at Dec. 31, 2022			16,923,981	80,606,229	8,101,770	45,286,589
Retroactive application of reverse recapitalization			$ 8,861		$ 3,573		(12,434)
Retroactive application of reverse recapitalization, shares			(63,682,248)		(37,184,819)
Issuance of common shares for asset acquisition	15,000,000				$ 4,066		14,995,934
Issuance of common shares for asset acquisition, shares					4,065,909
Shares repurchased, shares			(11,138)
Shares repurchased	(24,751)		$ (10)				(24,741)
Stock compensation expense	478,890						478,890
Net loss	(29,316,826)								(29,316,826)
Additional shares issued on reverse stock split, shares			(63,682,248)		(37,184,819)
Loss for the period	(29,316,826)
Ending Balance at Dec. 31, 2023	(1,558,746)		$ 16,913		$ 12,168		86,887,170		(88,474,997)
Ending Balance, shares at Dec. 31, 2023			16,912,843		12,167,679
Stock compensation expense	$ 1,958,663						1,958,663
Conversion of preferred stock to common stock			$ (16,913)		$ 16,913
Conversion of preferred stock to common stock, shares	16,912,843		(16,912,843)		16,912,843
Issuance of common stock upon settlement of convertible notes	$ 24,889,649				$ 9,867		24,879,782
Issuance of common stock upon settlement of convertible notes, shares					9,866,756
Reclassification of the derivative liability associated with the convertible notes make-whole premium	2,853,000						2,853,000
Common stock and preferred stock (assumed from merger) to Kintara shareholders in reverse recapitalization	(1,346,912)		$ 278,530		$ 1,843		(1,627,285)
Common stock and preferred stock (assumed from merger) to Kintara shareholders in reverse recapitalization, shares			278,530		1,842,920
Transaction costs in connection with the reverse recapitalization	(4,129,663)						(4,129,663)
Issuance of common shares, net of offering costs	4,600,000				$ 717		4,599,283
Issuance of common shares, net of offering costs, shares					717,322
Issuance of common shares for equity issuance and convertible notes for placement agent fees	443,560				$ 78		443,482
Issuance of common shares for equity issuance and convertible notes for placement agent fees, Shares					77,798
Issuance of common shares for warrants exercised	1,944,765				$ 647		1,944,118
Issuance of common shares for warrants exercised, Shares					646,580
Stock options exercised cash and cashless	$ 104,000				$ 92		103,908
Stock options exercised cash and cashless, Shares	180,689				91,862
Fair value of warrants associated with convertible notes payable	$ 6,520,056						6,520,056
Deemed dividend on warrant modifications	965,177						965,177		(965,177)
Net loss	(21,682,306)								(21,682,306)
Series A Preferred cash dividend	(2,089)								(2,089)
Loss for the period	(21,682,306)
Ending Balance at Dec. 31, 2024	$ 14,593,976		$ 278,530		$ 42,324		$ 125,397,691		$ (111,124,569)
Ending Balance, shares at Dec. 31, 2024			278,530		42,323,759